• J&J ordered to pay $4.68 billion to talc-powder plaintiffs pharmafile
    July 17, 2018
    A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women who claimed that the multinational’s talc-based products had caused them to develop ovarian cancer.
PharmaSources Customer Service